L. Ravindranath

发表

Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1.

N. Tran, S. Srivastava, G. Petrovics, 2006, DNA and cell biology.

Silencing of lactotransferrin expression by methylation in prostate cancer progression

V. Srikantan, S. Srivastava, I. Sesterhenn, 2007, Cancer biology & therapy.

Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens

T. Werner, I. Sesterhenn, M. Seifert, 2008, Prostate Cancer and Prostatic Diseases.

Prostate cancer marker panel with single cell sensitivity in urine

S. Srivastava, I. Sesterhenn, G. Petrovics, 2015, The Prostate.

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

V. Srikantan, J. Moul, S. Srivastava, 2006, Oncogene.

ABNORMAL CHOLESTEROL PROCESSING IN ALZHEIMER'S DISEASE PATIENT'S FIBROBLASTS

D. Alkon, Wei⁃qin Zhao, L. Ravindranath, 2003 .

Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression

T. Werner, V. Srikantan, I. Sesterhenn, 2012, Prostate Cancer and Prostatic Diseases.

Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer

Z. Szallasi, S. Srivastava, Hua Li, 2019, Cancers.

MAP Kinase Signaling Cascade Dysfunction Specific to Alzheimer's Disease in Fibroblasts

D. Alkon, C. Lyketsos, Wei⁃qin Zhao, 2002, Neurobiology of Disease.

Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence

S. Srivastava, I. Sesterhenn, S. Srivastava, 2019, Oncotarget.

Mapping of TMPRSS2–ERG fusions in the context of multi-focal prostate cancer

S. Srivastava, I. Sesterhenn, Yongmei Chen, 2008, Modern Pathology.

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population

S. Ambs, S. Srivastava, I. Sesterhenn, 2018, Prostate Cancer and Prostatic Diseases.

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

V. Srikantan, J. Moul, S. Srivastava, 2005, Oncogene.

Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer

Chen Sun, S. Srivastava, I. Sesterhenn, 2008, Clinical Cancer Research.

A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men

Z. Szallasi, M. Loda, I. Csabai, 2015, EBioMedicine.

Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer

S. Srivastava, I. Sesterhenn, Hua Li, 2014, Epigenetics.

Identification of a Small Molecule That Selectively Inhibits ERG-Positive Cancer Cell Growth.

J. Strovel, S. Srivastava, C. Dalgard, 2018, Cancer research.

Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells

S. Srivastava, Hua Li, E. Srivatsan, 2017, Molecular Cancer Research.

Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag

S. Srivastava, I. Sesterhenn, S. Srivastava, 2016, Genes & cancer.

Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence

S. Srivastava, I. Sesterhenn, S. Srivastava, 2010, Prostate Cancer and Prostatic Diseases.

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population

S. Ambs, S. Srivastava, I. Sesterhenn, 2018, Prostate Cancer and Prostatic Diseases.

Quantitative Expression of TMPRSS2 Transcript in Prostate Tumor Cells Reflects TMPRSS2-ERG Fusion Status

S. Srivastava, I. Sesterhenn, Yongmei Chen, 2009, Prostate Cancer and Prostatic Diseases.

Quantitative analysis of a panel of gene expression in prostate cancer—with emphasis on NPY expression analysis

S. Srivastava, G. Petrovics, L. Ravindranath, 2007, Journal of Zhejiang University SCIENCE B.

Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression

T. Werner, V. Srikantan, S. Srivastava, 2011, Prostate Cancer and Prostatic Diseases.

Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes

S. Srivastava, I. Sesterhenn, H. Pollard, 2022, Nature Communications.

Prostate Cancer Risk Allele Specific for African Descent Associates with Pathologic Stage at Prostatectomy

S. Srivastava, M. Freedman, Yongmei Chen, 2010, Cancer Epidemiology, Biomarkers & Prevention.

HYPOTHYROIDISM IN AYURVEDA - A CONCEPTUAL STUDY

L. Ravindranath, Kadlaskar B.B, 2015 .

Cellular functions and pathways affected by PCGEM1, a prostate-specific gene associated with African-American prostate cancer patients

Wei Zhang, J. Moul, S. Srivastava, 2004 .

Secretion of Annexin II via Activation of Insulin Receptor and Insulin-like Growth Factor Receptor*

D. Alkon, Hui Chen, M. Quon, 2003, The Journal of Biological Chemistry.

Association of TP53 Single Nucleotide Polymorphisms with Prostate Cancer in a Racially Diverse Cohort of Men

S. Srivastava, G. Petrovics, A. Dobi, 2023, Biomedicines.

Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer

Qiyuan Li, S. Srivastava, M. Freedman, 2020, Oncotarget.

Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.

S. Srivastava, I. Sesterhenn, Yongmei Chen, 2007, Urology.